Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.03
$0.141.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.72% | -48.97% | 9.85% | 18.46% | 24.29% |
| Total Depreciation and Amortization | -30.35% | -15.40% | -8.27% | -11.13% | -15.69% |
| Total Amortization of Deferred Charges | -89.36% | -74.35% | -51.94% | -29.95% | -12.39% |
| Total Other Non-Cash Items | 188.20% | 100.24% | 2.11% | -14.39% | -52.09% |
| Change in Net Operating Assets | -399.45% | -529.79% | -236.20% | -138.74% | -46.67% |
| Cash from Operations | -92.41% | -73.56% | -15.77% | 1.83% | 20.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.30% | 92.73% | -440.36% | -423.09% | -563.12% |
| Cash from Investing | 131.30% | 92.73% | -440.36% | -423.09% | -563.12% |
| Total Debt Issued | -- | -- | -- | -79.66% | -79.66% |
| Total Debt Repaid | -44.75% | -143.13% | -376.75% | -569.16% | -274.08% |
| Issuance of Common Stock | -75.40% | -32.91% | 87,857.00% | 87,857.00% | 70,494.20% |
| Repurchase of Common Stock | 91.56% | 91.56% | 91.56% | 7.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -81.97% | -42.24% | 6,004.93% | 24,258.13% | 485,288.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.75% | -29.23% | 205.95% | 784.07% | 188.03% |